Literature DB >> 7808866

Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.

J B Gouyon, A Benoit, P Bétremieux, D Sandre, C Sgro, F Bavoux, C Beneton, J Badoual.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7808866     DOI： 10.1097/00006454-199409000-00028

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.

Authors:  P C Ng; K W So; K S Fung; C H Lee; T F Fok; E Wong; W Wong; K L Cheung; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Fluoroquinolones in paediatrics.

Authors:  D Gendrel; F Moulin
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.

Authors:  Sriparna Basu; Susan Smith
Journal:  Eur J Pediatr       Date:  2020-10-12       Impact factor: 3.183

Review 4.  Erythromycin as a prokinetic agent in preterm neonates: a systematic review.

Authors:  S Patole; S Rao; D Doherty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-17       Impact factor: 5.747

5.  Pharmacological therapy of gastroesophageal reflux in preterm infants.

Authors:  Luigi Corvaglia; Caterina Monari; Silvia Martini; Arianna Aceti; Giacomo Faldella
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

6.  High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.

Authors:  Pak C Ng; Cheuk H Lee; Samuel P S Wong; Hugh S Lam; Flora Y B Liu; King W So; Cheuk Y Lee; Tai F Fok
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.